SlideShare a Scribd company logo
1 of 8
Download to read offline
PRESENTED BY:
The Wien Center for Alzheimer’s Disease and Memory Disorders
Mount Sinai Medical Center, Miami Beach, Florida
and
The Johnnie B. Byrd, Sr. Alzheimer’s Center & Research Institute
Tampa, Florida
and
The Florida Alzheimer’s Disease Research Center
Friday–Saturday, February 24-25, 2006
SYMPOSIUM LOCATION:
Eden Roc Resort & Spa
4525 Collins Ave., Miami Beach, FL 33140
PROGRAM DIRECTOR
Ranjan Duara, MD
Medical Director
Wien Center for Alzheimer’s Disease & Memory Disorders
Mount Sinai Medical Center, Miami Beach, FL
Departments of Medicine and Psychiatry
Miller School of Medicine, University of Miami, Miami, FL
SPONSORED BY:
THE BEHRMAN CENTER FOR MEDICAL EDUCATION
AT MOUNT SINAI MEDICAL CENTER
An accredited interactive Symposium offering
15 hours of Category 1 credits for Physicians
and 15 CEU accreditation hours for Psychologists offered through MAGEC.
MILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUMMILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUM
44TH
ANNUAL
MCI Brochure 06 12/5/05 2:23 PM Page 2
NEEDS ASSESSMENT
Alzheimer’s Disease affects over 4 million
persons in the United States and this
number is projected to increase to over 13
million by 2050, due to increases in
longevity and the aging of baby boomers.
Continuing success in the development of
new treatments and preventive measures
for Alzheimer’s disease and other causes
of dementia have prompted the need for a
better recognition of the earliest stages of
these conditions. The purpose of this
symposium is to provide a forum where
new information can be provided and in-
depth discussions can take place about
Mild Cognitive Impairment and all its
subtypes. This will be accomplished via
two keynote lectures and four mini-
symposia. The symposium will feature a
panel of national and international
experts in the fields of neurology,
psychiatry, geriatrics, neuropsychology,
brain imaging, neuropathology and
epidemiology. These experts will present
updates on the early detection of incipient
dementias and their causes, prevention
and treatment. Each mini-symposium
will be followed by an extended
discussion period, allowing active
audience participation to enhance the
learning process.
TARGET AUDIENCE
This activity is designed for:
– Neurologists
– Psychiatrists
– Geriatricians
– Radiologists (neuroimaging specialists)
– Epidemiologists
– Neuropsychologists
– Neuroscientists
– Health Psychologists
EDUCATIONAL OBJECTIVES
The overall purpose of the symposium is to promote a better
understanding and earlier diagnosis of mild cognitive
impairment (MCI) and preclinical dementia. Upon completion
of this symposium, the attendees should have a better
understanding of the following:
1. Cognitive Reserve and MCI
a. Cognitive reserve: Concept, measurement and significance
for MCI
b. Insights from longitudinal studies of aging
c. Cognitive reserve perspectives from neuroimaging,
neuropathology, and neuropsychology
2. Genetics of Cognitive Decline
a. Inheritance of memory and cognitive performance in
siblings of persons with Alzheimer’s Disease (AD)
b. Genetics and gene expression of early AD and MCI
c. Contribution of vascular genes in AD
d. Genetics of the “normal” aging brain
e. Prediction of MCI with plasma amyloid beta protein levels
3. Pathogenesis of Vascular/Metabolic Cognitive Impairment
a. Cognitive impairment following stroke
b. Epidemiology of vascular cognitive impairment
c. Neuroimaging and neuropathology of vascular cognitive
impairment
4. Systemic (Medical) and Psychiatric Considerations in MCI
Diagnosis
a. Contribution of physiological health to cognitive ability
b. Effect of chemotherapy on cognitive function
c. Effect of HIV infection and hepatitis C on cognition
d. Depression and the diagnosis of MCI
e. Anticholinergics, Benzodiazepines and MCI
5. Results of clinical trials in patients with MCI
MCI Brochure 06 12/5/05 2:23 PM Page 3
David A. Bennett, MD
Professor of Neurological Sciences
Rush University Medical Center
Chicago, IL
Monique Breteler, MD, PhD
Professor of Neuroepidemiology
Erasmus University Medical School
Rotterdam, Netherlands
Meryl Butters, PhD
Associate Professor of Psychiatry
University of Pittsburgh School of Medicine
Pittsburgh, PA
Mariana Cherner, PhD
Assistant Professor of Psychiatry
University of California San Diego School of Medicine
San Diego, CA
Helena Chui, MD
McCarron Professor and Chair of Neurology
University of Southern California Keck School of
Medicine
Los Angeles, CA
Fiona Crawford, PhD
Associate Director, Roskamp Institute
Sarasota, FL
Charles DeCarli, MD
Professor of Neurology
University of California Davis School of Medicine
Sacramento, CA
Steven DeKosky, MD
Professor and Chairman of Neurology
University of Pittsburgh School of Medicine
Pittsburgh, PA
Murali Doraiswamy, MD
Director, Clinical Trials and Head, Biological Psychiatry
Duke University Medical Center
Durham, NC
Lindsay Farrer, PhD
Professor of Medicine, Neurology, Genetics & Genomics,
Epidemiology, & Biostatistics
Boston University Medical School
Boston, MA
Mary Ganguli, MD, MPH
Professor of Psychiatry and Epidemiology
University of Pittsburgh School of Medicine
Pittsburgh, PA
Cheryl Grady, PhD
Professor of Psychiatry & Psychology
Rotman Research Institute, University of Toronto
Toronto, ON Canada
Mary Haan, DrPH
Professor of Epidemiology
University of Michigan School of Public Health
Ann Arbor, MI
Walter Kukull, PhD, MS
Professor of Epidemiology
University of Washington School of Public Health
and Community Medicine
Seattle, WA
Anand Kumar, MD
Professor of Psychiatry
University of California
Los Angeles, CA
Lenore Launer, PhD
Chief, Neuroepidemiology Section
National Institute on Aging
Bethesda, MD
Venkata Mattay, MD
Chief, Unit on Clinical Neuroimaging
National Institute of Metal Health
Bethesda, MD
Richard Mayeux, MD, MSc
Professor of Neurology, Psychiatry and Epidemiology
Columbia University College of Physicians and
Surgeons
New York, NY
John Morris, MD
Friedman Distinguished Professor of Neurology
Washington University School of Medicine
St. Louis, MO
Daniel Mungas, PhD
Adjunct Associate Professor of Neurology
UC Davis School of Medicine
Sacramento, CA
Giulio Pasinetti, MD, PhD
Professor, Psychiatry, Neuroscience & Geriatrics and
Adult Development
Mount Sinai School of Medicine
New York, NY
Ronald Petersen, MD, PhD
Professor of Neurology and Alzheimer’s Disease
Research
Mayo Medical School, Rochester
Rochester, MN
Gustavo Roman, MD
Professor of Neurology
University of Texas Medical School
San Antonio, TX
Julie Schneider, MD
Assistant Professor of Neurology and
Neuropathology
Rush University Medical Center
Chicago, IL
Brent Small, PhD
Associate Professor of Aging Studies
University of South Florida
Tampa, FL
Peter St. George-Hyslop, MD, DSc
Professor of Neurology and Genetics
University of Toronto
Toronto, ON Canada
John Starr, MD
Consultant and Senior Lecturer, Geriatric Medicine
University of Edinburgh
Edinburgh, Scotland UK
Yaakov Stern, PhD
Professor of Clinical Neuropsychology
Columbia University College of Physicians and
Surgeons
New York, NY
Larry Tune, MD, MAS
Professor and Chief of Geriatric Psychiatry
Emory University
Atlanta, GA
Holly Tuokko, PhD
Professor of Psychology
University of Victoria
Victoria, BC Canada
Jeffrey Wefel, PhD
Department of Neuro-Oncology
University of Texas M.D. Anderson Cancer Center
Houston, TX
Lawrence Whalley, MD
Crombie Ross Professor of Mental Health
University of Aberdeen
Aberdeen, Scotland UK
Steven Younkin, MD, PhD
Professor of Pharmacology and Pathology
Mayo Clinic
Jacksonville, FL
DISTINGUISHED GUEST FACULTY
Program Director
Ranjan Duara, MD
Medical Director, Wien Center for Alzheimer’s Disease & Memory Disorders
Mount Sinai Medical Center, Miami Beach, FL
Departments of Medicine and Psychiatry, Miller School of Medicine
University of Miami, FL
MCI Brochure 06 12/5/05 2:23 PM Page 4
PM
2:00-4:15 Mini-Symposium: Genetics and Proteomics of
Cognitive Decline
Chair: Richard Mayeux, MD, MSc
– Inheritance of Memory and Other Cognitive
Functions in Siblings of AD Patients
Richard Mayeux, MD, MSc
– Genetic Factors in Alzheimer’s Disease and
MCI
Peter St. George-Hyslop, MD, DSc
– Association of Vascular-Related Genes with
AD
Lindsay Farrer, PhD
– Imaging Genetic Influences in Normal
Cognitive Aging
Venkata (Anand) Mattay, MD
– Gene Expression Analysis and Proteomics in
MCI and Early AD
Giulio Pasinetti, MD, PhD
– Plasma Amyloid Beta Protein Levels and the
Prediction of MCI
Steve Younkin, MD, PhD
4:15-5:15 Invited Discussant (Fiona Crawford, PhD) and
General Discussion
5:15 Adjourn
7:00-9:00 Welcome Dinner
Friday, February 24, 2006
AM
7:00-8:00 Breakfast Buffet
8:00-8:15 Welcome and Introduction
Ranjan Duara MD
8:15-9:15 Vascular Risk Factors and Cognitive
Reserve in the Evolution of Cognitive
Decline and Dementia: Lessons from
the Rotterdam Study
Monique Breteler, MD,PhD –
Keynote Speaker
9:15-11:30 Mini-Symposium: Cognitive Reserve
and MCI
Chair: Ronald Petersen, PhD, MD
– Cognitive Reserve: Concept,
Measurement and Significance for
MCI
Yaakov Stern, PhD
– Cognitive Reserve: Insights from the
Scottish Mental Survey (1947 &
1998)
Lawrence Whalley, MD
– Cognitive Reserve and the
Neuropsychological Diagnosis of
MCI
Holly Tuokko, PhD
– Cognitive Reserve: Structural
Neuroimaging
Daniel Mungas, PhD
– Cognitive Reserve: Functional
Neuroimaging
Cheryl Grady, PhD
– Cognitive Reserve and the
Expression of AD Neuropathology
David Bennett, MD
11:30-12:30 Invited Discussant (Walter Kukull, PhD
and Brent Small, PhD) and General
Discussion
12:30-2:00 LUNCH BREAK
MCI Brochure 06 12/5/05 2:23 PM Page 5
AM
7:00-8:00 Breakfast Buffet
8:00-8:15 Announcements and Introductions
Ranjan Duara, MD
8:15-9:15 A Review of Clinical Trials in MCI
Murali Doraiswamy, MD -
Keynote Speaker
9:15-11:30 Mini-Symposium: Pathogenesis of
Vascular/Metabolic Cognitive
Impairment
Chair: Steven DeKosky, MD
– Pathogenesis of Cognitive
Impairment Following Stroke
Gustavo Roman, MD
– Epidemiology of Vascular
Cognitive Impairment
Lenore Launer, PhD
– Diabetes Mellitus and MCI
Mary Haan, DrPH
– Neuroimaging and Neuropatholgy
in Vascular Cognitive Impairment
Helena Chui, MD
– Co-existence of Vascular and
Alzheimer Pathology in
Cognitively Impaired Individuals
Julie Schneider, MD
– Significance of White Matter
Hyperintensities in MCI
Charles DeCarli, MD
11:30-12:30 Invited Discussant (Richard Mayeux,
MD, MSc) and General Discussion
12:30-2:00 LUNCH BREAK
PM
2:00-4:00 Mini-Symposium: Systemic (Medical) and
Psychiatric Considerations in MCI
Chair: John Morris, MD
– Physiological Health and Cognitive
Ability in Aging
John Starr, FRCP
– Cancer, Chemotherapy and MCI
Jeffrey Wefel, PhD
– HIV infection, Hepatitis C and MCI
Mariana Cherner, PhD
– Depression, Vascular Disease & MCI
Anand Kumar, MD
– Anticholinergics, Benzodiazepines and
MCI
Larry Tune, MD
4:00-5:00 Invited Discussant (Mary Ganguli, MD,
MPH and Meryl Butters, PhD) and General
Discussion
5:00 Adjourn
Saturday, February 25, 2006
MCI Brochure 06 12/5/05 2:23 PM Page 6
METHOD OF
REGISTRATION
To register by mail or fax: please complete
the registration form and send it with the
payment to the above mailing address or
fax number.
To register by email: provide the
information requested on the registration
form in an e-mail message and send to:
mcisymposium@msmc.com
Registration confirmations will be issued.
Payment: Registration fees can be paid by
credit card or check, no cash is accepted.
Please make all checks payable to MCI
SYMPOSIUM, MSMC.
Registration Fee Inclusions: Registration
fees include admittance to all the scientific
conferences, conference materials,
validated parking, breakfast, lunch,
refreshment breaks and welcome dinner as
specified in the program.
Registration Hours: The conference
registration desk will be staffed:
Friday, February 24 –
Meeting Room: Cotillion Room
7:00 am - 5:00 pm
Lunch: Topiary Garden
12:30 pm - 2:00 pm
Welcome Dinner
7:00 pm - 9:00 pm
Saturday, February 25 –
Meeting Room: Cotillion Room
7:00 am - 5:00 pm
Lunch: Harry’s
12:30 pm - 2:00 pm
Refund Policy: Full refund will be given if written notice is received not later than January 27, 2006.
All refunds will be processed after the meeting.
REGISTRATION INFORMATION
SYMPOSIUM LOCATION
EDEN ROC RESORT & SPA:
4525 Collins Ave, Miami Beach, FL 33140
Phone: 1-800-327-8337 • Fax: 1-305-674-5555
Located on prime oceanfront property
overlooking world-renowned Miami Beach
and the spectacular Intracoastal Waterway,
the 349-room Eden Roc Renaissance has
been magnificently restored. From the
beautifully carved Italian
marble and mahogany
reception desk to the
highly polished original
terrazzo floors, to the
stunning grand circular
lobby, the Eden Roc
Renaissance welcomes
guests with a gracious
new contemporary spirit.
Resort amenities include the Spa of
Eden, one of the top fitness spas in the
country, and two oceanfront pools.
Directly behind the hotel is a raised 3-
mile board walk, which invites leisure
strolling or jogging next to the ocean.
The world-famous South Beach Art Deco District and Lincoln Road
Pedestrian Mall are just minutes away.
HOTEL RESERVATIONS
For the convenience of the 4th Annual
MCI Symposium attendees, a limited
number of rooms have been reserved
at the special daily rate of $269.00
(single or double occupancy, plus
resort fees, state and local taxes). To
receive this special rate, reservations
must be made directly with the Eden
Roc Resort and Spa and you must
mention that you are a registrant of the 4th Annual MCI
Symposium. Rooms will be held at the special rate until Tuesday,
January 27, 2006. Rooms at the discounted rate will be allocated
on a first-come, first-served basis. Reservations received after the
cut-off date are subject to availability and prevailing rates.
FOR ROOM RESERVATIONS CALL: 1-800-327-8337
OR ACCESS THE HOTEL WEB SITE VIA
www.byrdinstitute.org/MCISymposium
MCI Brochure 06 12/5/05 2:23 PM Page 7
44TH
ANNUAL MILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUMMILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUM
REGISTRATION FORM
THREE EASY WAYS TO REGISTER:
ON LINE FAX US MAIL US
www.byrdinstitute.org/MCISymposium Attn: Warren Barker Warren Barker
Fax to (305) 674-2996 Wien Center
4300 Alton Road
Miami Beach, FL 33140
REGISTRANT INFORMATION Please print:
_________________________________________________________________________________________
LAST NAME FIRST NAME MI
DEGREE: MD DO Ph.D OTHER ____________________________________________
_________________________________________________________________________________________
ADDRESS
_________________________________________________________________________________________
CITY STATE ZIP CODE COUNTRY
_________________________________________________________________________________________
E-MAIL FAX TELEPHONE
REGISTRATION FEES:
Physicians: Discounted: $290.00 (if dated/postmarked by January 27)
$390.00 (if dated/postmarked after January 27)
$450.00 (on site registration)
Non-Physicians: Discounted: $225.00 (if dated/postmarked by January 27)
$275.00 (if dated/postmarked after January 27)
$325.00 (on site registration)
$100.00 (students)
PAYMENT METHOD:
American Express Master Card Visa Check in the amount of________________
Card No. ________________________________________________ Expiration Date _____/_____
Cardholder’s Name _________________________________________________________________
Signature __________________________________________________________________________
Payment must accompany registration form
MCI Brochure 06 12/5/05 2:23 PM Page 8
ACCREDITATION
Mount Sinai Medical Center is
accredited by the Accreditation
Council for Continuing
Medical Education (ACCME)
to sponsor continuing medical
education for physicians.
Mount Sinai designates this
continuing medical
educational activity for a
maximum of 15 Category 1
credits toward the American
Medical Association Physician’s
Recognition Award (AMA).
Each physician should claim
only those hours of credit that
he/she actually spent in the
educational activity.
CEU ACCREDITATION
A total of 15 Continuing
Education credits for
Psychologists will be offered
through MAGEC (Miami Area
Geriatric Education Center)
DISCLOSURE STATEMENT
Mount Sinai Medical Center in accordance with the Standards for Commercial
Support of the Accreditation Council for Continuing Medical Education (ACCME)
will disclose the existence of any significant financial interest or other relationship
between a faculty member or a sponsor has (1) with the manufacturer(s) of any
commercial product(s) and/or provider(s) of commercial services discussed in the
educational presentation and (2) with any commercial supporters of the activity.
Faculty is also required to disclose to the audience, during their presentation, any
investigational/ unlabeled use that is discussed. Information concerning Faculty
relationship with industry will be disclosed and available on the Symposium
Syllabus and on meeting site.
CORPORATE SUPPORT
This symposium is made possible by unrestricted educational grants from
pharmaceuticals companies; our appreciation is expressed for their support of this
program. Sponsors will be listed in our Symposium Syllabus.
ACKNOWLEDGMENT
This symposium is being supported by the Florida Alzheimer’s Disease Research
Center.
SYMPOSIUM INFORMATION
Please contact: Warren Barker
MCI Symposium Coordinator
Wien Center for Alzheimer’s Disease & Memory Disorders
Mount Sinai Medical Center
Phone: 305-674-2592 – Fax: 305-674-2996
E-mail: mcisymposium@msmc.com
Wien Center
4300 Alton Road
Miami Beach, FL 33140
44TH
ANNUAL
MCIS Y M P O S I U M
FEBRUARY
24th & 25th
2006
For information please contact:
Warren Barker
Phone: 305-674-2592
mcisymposium@msmc.com
www.byrdinstitute.org/MCISymposium
MCIS Y M P O S I U M
For information please contact:
Warren Barker
Phone: 305-674-2592
mcisymposium@msmc.com
www.byrdinstitute.org/MCISymposium
MCI Brochure 06 12/5/05 2:23 PM Page 1

More Related Content

What's hot

Deciding When Hospice Care is Needed | VITAS Healthcare
Deciding When Hospice Care is Needed | VITAS HealthcareDeciding When Hospice Care is Needed | VITAS Healthcare
Deciding When Hospice Care is Needed | VITAS HealthcareVITAS Healthcare
 
2010 mstar graduation -final
2010 mstar graduation -final2010 mstar graduation -final
2010 mstar graduation -finalcrobin44
 
Evaluation and Management of Behaviors in Persons with Cognitive Impairment
Evaluation and Management of Behaviors in Persons with Cognitive ImpairmentEvaluation and Management of Behaviors in Persons with Cognitive Impairment
Evaluation and Management of Behaviors in Persons with Cognitive ImpairmentVITAS Healthcare
 
Persistent Vegetative State
Persistent Vegetative StatePersistent Vegetative State
Persistent Vegetative StateVITAS Healthcare
 
Respiratory Symptoms in the Terminally Ill Patient
Respiratory Symptoms in the Terminally Ill PatientRespiratory Symptoms in the Terminally Ill Patient
Respiratory Symptoms in the Terminally Ill PatientVITAS Healthcare
 
58895420 case-study2-final-revised-na-tlga-to
58895420 case-study2-final-revised-na-tlga-to58895420 case-study2-final-revised-na-tlga-to
58895420 case-study2-final-revised-na-tlga-tohomeworkping3
 
Preventive predictive-and-personalized-medicine
Preventive predictive-and-personalized-medicinePreventive predictive-and-personalized-medicine
Preventive predictive-and-personalized-medicinecancerdrg
 
Nutrition and Hydration in the Hospice Patient
Nutrition and Hydration in the Hospice PatientNutrition and Hydration in the Hospice Patient
Nutrition and Hydration in the Hospice PatientVITAS Healthcare
 
Developmental Disabilities and Community Life
Developmental Disabilities and Community LifeDevelopmental Disabilities and Community Life
Developmental Disabilities and Community LifeRoss Finesmith
 
Developmental disabilities symposium chapter
Developmental disabilities symposium chapterDevelopmental disabilities symposium chapter
Developmental disabilities symposium chapterRoss Finesmith M.D.
 
Advanced Cancer and End of Life
Advanced Cancer and End of LifeAdvanced Cancer and End of Life
Advanced Cancer and End of LifeVITAS Healthcare
 
Advanced Lung Disease: Prognostication and Role of Hospice
Advanced Lung Disease: Prognostication and Role of HospiceAdvanced Lung Disease: Prognostication and Role of Hospice
Advanced Lung Disease: Prognostication and Role of HospiceVITAS Healthcare
 
Cosby High School Pre-Med
Cosby High School Pre-MedCosby High School Pre-Med
Cosby High School Pre-MedMark Ryan
 
Pattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adultsPattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adultsdrkalyanir
 

What's hot (20)

CV Jeffrey Gerdes 2015
CV Jeffrey Gerdes 2015CV Jeffrey Gerdes 2015
CV Jeffrey Gerdes 2015
 
Dr. Jeffrey Gerdes, D.C. 2016 CV
Dr. Jeffrey Gerdes, D.C. 2016 CVDr. Jeffrey Gerdes, D.C. 2016 CV
Dr. Jeffrey Gerdes, D.C. 2016 CV
 
Resident 2018 - cog care in primary care
Resident 2018 - cog care in primary careResident 2018 - cog care in primary care
Resident 2018 - cog care in primary care
 
Deciding When Hospice Care is Needed | VITAS Healthcare
Deciding When Hospice Care is Needed | VITAS HealthcareDeciding When Hospice Care is Needed | VITAS Healthcare
Deciding When Hospice Care is Needed | VITAS Healthcare
 
2010 mstar graduation -final
2010 mstar graduation -final2010 mstar graduation -final
2010 mstar graduation -final
 
Evaluation and Management of Behaviors in Persons with Cognitive Impairment
Evaluation and Management of Behaviors in Persons with Cognitive ImpairmentEvaluation and Management of Behaviors in Persons with Cognitive Impairment
Evaluation and Management of Behaviors in Persons with Cognitive Impairment
 
Persistent Vegetative State
Persistent Vegetative StatePersistent Vegetative State
Persistent Vegetative State
 
Respiratory Symptoms in the Terminally Ill Patient
Respiratory Symptoms in the Terminally Ill PatientRespiratory Symptoms in the Terminally Ill Patient
Respiratory Symptoms in the Terminally Ill Patient
 
58895420 case-study2-final-revised-na-tlga-to
58895420 case-study2-final-revised-na-tlga-to58895420 case-study2-final-revised-na-tlga-to
58895420 case-study2-final-revised-na-tlga-to
 
Preventive predictive-and-personalized-medicine
Preventive predictive-and-personalized-medicinePreventive predictive-and-personalized-medicine
Preventive predictive-and-personalized-medicine
 
Nutrition and Hydration in the Hospice Patient
Nutrition and Hydration in the Hospice PatientNutrition and Hydration in the Hospice Patient
Nutrition and Hydration in the Hospice Patient
 
Developmental Disabilities and Community Life
Developmental Disabilities and Community LifeDevelopmental Disabilities and Community Life
Developmental Disabilities and Community Life
 
ddsymposiumchapt
ddsymposiumchaptddsymposiumchapt
ddsymposiumchapt
 
Ddsymposiumchapt
DdsymposiumchaptDdsymposiumchapt
Ddsymposiumchapt
 
Developmental disabilities symposium chapter
Developmental disabilities symposium chapterDevelopmental disabilities symposium chapter
Developmental disabilities symposium chapter
 
Advanced Cancer and End of Life
Advanced Cancer and End of LifeAdvanced Cancer and End of Life
Advanced Cancer and End of Life
 
Advanced Lung Disease: Prognostication and Role of Hospice
Advanced Lung Disease: Prognostication and Role of HospiceAdvanced Lung Disease: Prognostication and Role of Hospice
Advanced Lung Disease: Prognostication and Role of Hospice
 
Cosby High School Pre-Med
Cosby High School Pre-MedCosby High School Pre-Med
Cosby High School Pre-Med
 
Breanna Schnitger, KSU Phlebotomy Graduate
Breanna Schnitger, KSU Phlebotomy GraduateBreanna Schnitger, KSU Phlebotomy Graduate
Breanna Schnitger, KSU Phlebotomy Graduate
 
Pattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adultsPattern of cancer in adolescent and young adults
Pattern of cancer in adolescent and young adults
 

Similar to MCI brochure 2006

Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...Nutricia
 
Vemuri alz forum
Vemuri alz forumVemuri alz forum
Vemuri alz forumAlzforum
 
2017 Washington Neuroradiology and Neuropathology Review Courses
2017 Washington Neuroradiology and Neuropathology Review Courses2017 Washington Neuroradiology and Neuropathology Review Courses
2017 Washington Neuroradiology and Neuropathology Review CoursesMichele Theiss
 
Annals of behavioral medicine volume 49 issue 1 supplement april 2015
Annals of behavioral medicine volume 49 issue 1 supplement april 2015Annals of behavioral medicine volume 49 issue 1 supplement april 2015
Annals of behavioral medicine volume 49 issue 1 supplement april 2015Monique Tsang, BS, CNA
 
Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015
Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015
Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015Monique Tsang, BS, CNA
 
Mayo Clinic - 2011 ACC Satellite Education Symposiums
Mayo Clinic - 2011 ACC Satellite Education SymposiumsMayo Clinic - 2011 ACC Satellite Education Symposiums
Mayo Clinic - 2011 ACC Satellite Education Symposiumswest0521
 
ppt for scientific session.pptx
ppt for scientific session.pptxppt for scientific session.pptx
ppt for scientific session.pptxanushajupudi
 
Toward defining the preclinical stages of Alzheimer's disease
Toward defining the preclinical stages of Alzheimer's diseaseToward defining the preclinical stages of Alzheimer's disease
Toward defining the preclinical stages of Alzheimer's diseaseDario Yac
 
Seventh Annual Next Generation Dx Summit
Seventh Annual Next Generation Dx SummitSeventh Annual Next Generation Dx Summit
Seventh Annual Next Generation Dx SummitJaime Hodges
 
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicNext Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicJames Prudhomme
 
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...InsSilva801685
 
Pediatric neurology
Pediatric neurologyPediatric neurology
Pediatric neurologyImad Zoukar
 
Michael Liebman (IPQ Analytics) Applying Digital Technologies to Rare Disea...
 Michael Liebman (IPQ Analytics)  Applying Digital Technologies to Rare Disea... Michael Liebman (IPQ Analytics)  Applying Digital Technologies to Rare Disea...
Michael Liebman (IPQ Analytics) Applying Digital Technologies to Rare Disea...Canadian Organization for Rare Disorders
 
MedicalResearch.com: Medical Research Exclusive Interviews July 2 2015
MedicalResearch.com:  Medical Research Exclusive Interviews July 2 2015MedicalResearch.com:  Medical Research Exclusive Interviews July 2 2015
MedicalResearch.com: Medical Research Exclusive Interviews July 2 2015Marie Benz MD FAAD
 
Diagnostic Assessments
Diagnostic AssessmentsDiagnostic Assessments
Diagnostic AssessmentsLiz Harris
 

Similar to MCI brochure 2006 (20)

Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...
Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Con...
 
Vemuri alz forum
Vemuri alz forumVemuri alz forum
Vemuri alz forum
 
2017 Washington Neuroradiology and Neuropathology Review Courses
2017 Washington Neuroradiology and Neuropathology Review Courses2017 Washington Neuroradiology and Neuropathology Review Courses
2017 Washington Neuroradiology and Neuropathology Review Courses
 
2017NPNRBrochure
2017NPNRBrochure2017NPNRBrochure
2017NPNRBrochure
 
Annals of behavioral medicine volume 49 issue 1 supplement april 2015
Annals of behavioral medicine volume 49 issue 1 supplement april 2015Annals of behavioral medicine volume 49 issue 1 supplement april 2015
Annals of behavioral medicine volume 49 issue 1 supplement april 2015
 
Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015
Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015
Annals of Behavioral Medicine Volume 49-Issue 1 Supplement-April 2015
 
Mayo Clinic - 2011 ACC Satellite Education Symposiums
Mayo Clinic - 2011 ACC Satellite Education SymposiumsMayo Clinic - 2011 ACC Satellite Education Symposiums
Mayo Clinic - 2011 ACC Satellite Education Symposiums
 
Liljana Trenova
Liljana TrenovaLiljana Trenova
Liljana Trenova
 
ppt for scientific session.pptx
ppt for scientific session.pptxppt for scientific session.pptx
ppt for scientific session.pptx
 
Toward defining the preclinical stages of Alzheimer's disease
Toward defining the preclinical stages of Alzheimer's diseaseToward defining the preclinical stages of Alzheimer's disease
Toward defining the preclinical stages of Alzheimer's disease
 
Seventh Annual Next Generation Dx Summit
Seventh Annual Next Generation Dx SummitSeventh Annual Next Generation Dx Summit
Seventh Annual Next Generation Dx Summit
 
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the ClinicNext Generation Dx Summit 2015 - Moving Assays to the Clinic
Next Generation Dx Summit 2015 - Moving Assays to the Clinic
 
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics ( PDFDrive...
 
Pediatric neurology
Pediatric neurologyPediatric neurology
Pediatric neurology
 
Michael Liebman (IPQ Analytics) Applying Digital Technologies to Rare Disea...
 Michael Liebman (IPQ Analytics)  Applying Digital Technologies to Rare Disea... Michael Liebman (IPQ Analytics)  Applying Digital Technologies to Rare Disea...
Michael Liebman (IPQ Analytics) Applying Digital Technologies to Rare Disea...
 
Coplin_CV_bio_060914
Coplin_CV_bio_060914Coplin_CV_bio_060914
Coplin_CV_bio_060914
 
Manual
ManualManual
Manual
 
CV RHC 82016 UM Format
CV RHC 82016 UM FormatCV RHC 82016 UM Format
CV RHC 82016 UM Format
 
MedicalResearch.com: Medical Research Exclusive Interviews July 2 2015
MedicalResearch.com:  Medical Research Exclusive Interviews July 2 2015MedicalResearch.com:  Medical Research Exclusive Interviews July 2 2015
MedicalResearch.com: Medical Research Exclusive Interviews July 2 2015
 
Diagnostic Assessments
Diagnostic AssessmentsDiagnostic Assessments
Diagnostic Assessments
 

More from wef

Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"wef
 
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"wef
 
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"wef
 
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?wef
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorderswef
 
NIMH i PSC Assays for the Drug Pipeline - Panchision
NIMH i PSC Assays for the Drug Pipeline -  PanchisionNIMH i PSC Assays for the Drug Pipeline -  Panchision
NIMH i PSC Assays for the Drug Pipeline - Panchisionwef
 
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage wef
 
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen BrennandSCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennandwef
 
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...wef
 
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...wef
 
Dopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the ProdromeDopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the Prodromewef
 
Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...wef
 
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...wef
 
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...wef
 
Alzheimer's and memory loss 101
Alzheimer's and memory loss 101Alzheimer's and memory loss 101
Alzheimer's and memory loss 101wef
 
Christoph Correll
Christoph CorrellChristoph Correll
Christoph Correllwef
 
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...wef
 
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...wef
 
HEAR approach to behavior management Live webinar Feb 1 2017
HEAR approach to behavior management   Live webinar Feb 1 2017HEAR approach to behavior management   Live webinar Feb 1 2017
HEAR approach to behavior management Live webinar Feb 1 2017wef
 
LBDA Webinar Bradley Boeve
LBDA Webinar Bradley BoeveLBDA Webinar Bradley Boeve
LBDA Webinar Bradley Boevewef
 

More from wef (20)

Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
Robin Murray commentary during the SRF webinar "Is Schizophrenia Dead Yet?"
 
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
Eske Derks commentary - SRF webinar "Is Schizophrenia Dead Yet?"
 
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
Jim van Os presentation during SRF live webinar "Is Schizophrenia Dead Yet?"
 
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
Rene Kahn commentary during SRF Live Webinar: "Is Schizophrenia Dead Yet?
 
Mark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disordersMark Daly - Finding risk genes in psychiatric disorders
Mark Daly - Finding risk genes in psychiatric disorders
 
NIMH i PSC Assays for the Drug Pipeline - Panchision
NIMH i PSC Assays for the Drug Pipeline -  PanchisionNIMH i PSC Assays for the Drug Pipeline -  Panchision
NIMH i PSC Assays for the Drug Pipeline - Panchision
 
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage
 
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen BrennandSCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017   Kristen Brennand
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennand
 
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...
 
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...
 
Dopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the ProdromeDopamine: Stress, Genes and the Prodrome
Dopamine: Stress, Genes and the Prodrome
 
Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...Topography and functional significance of the dopaminesgic dysfunction in sch...
Topography and functional significance of the dopaminesgic dysfunction in sch...
 
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...
 
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...
 
Alzheimer's and memory loss 101
Alzheimer's and memory loss 101Alzheimer's and memory loss 101
Alzheimer's and memory loss 101
 
Christoph Correll
Christoph CorrellChristoph Correll
Christoph Correll
 
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...
 
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...
 
HEAR approach to behavior management Live webinar Feb 1 2017
HEAR approach to behavior management   Live webinar Feb 1 2017HEAR approach to behavior management   Live webinar Feb 1 2017
HEAR approach to behavior management Live webinar Feb 1 2017
 
LBDA Webinar Bradley Boeve
LBDA Webinar Bradley BoeveLBDA Webinar Bradley Boeve
LBDA Webinar Bradley Boeve
 

Recently uploaded

INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptKavitha Krishnan
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdfHongBiThi1
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisAshishMaletha2
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...Genesis Institute of Pharmacy, Radhanagari.
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCEShubhadip Ghosh
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxsiddharthroy26587
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Ahmad Thanin
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionZeinabEmad3
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUKanhu Charan
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedSBL DIGITAL
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptxnakera38
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxRajendra Dev Bhatt
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)chahattyagi200
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfMayuriGamit2
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyYves Sucaet
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...JakeMatthews12
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptxPulkitMittal54
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......anupamdas2143
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsPradnya Wadekar
 

Recently uploaded (20)

INTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.pptINTRODUCTION TO THE FORENSIC SCIENCE.ppt
INTRODUCTION TO THE FORENSIC SCIENCE.ppt
 
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
SGK PHÙ PHỔI CẤP ĐHYHN                   .pdfSGK PHÙ PHỔI CẤP ĐHYHN                   .pdf
SGK PHÙ PHỔI CẤP ĐHYHN .pdf
 
Basic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth AnalysisBasic of Thyroid Hormone:- An In-depth Analysis
Basic of Thyroid Hormone:- An In-depth Analysis
 
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
HDT Unit 2: Nutraceuticals Global Market Overview And Growth Of Nutraceutical...
 
CELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCECELL BLOCK PREPARATION AND ITS IMPORTANCE
CELL BLOCK PREPARATION AND ITS IMPORTANCE
 
Spinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptxSpinal cord Gross anatomy with Clinical Anatomy.pptx
Spinal cord Gross anatomy with Clinical Anatomy.pptx
 
Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)Methicillin-resistant Staphylococcus Aureus (MRSA)
Methicillin-resistant Staphylococcus Aureus (MRSA)
 
Substance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), AddictionSubstance use disorder (drug addict ), Addiction
Substance use disorder (drug addict ), Addiction
 
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHUTARGET DELINEATION IN VULVAL CANCER BY DR KANHU
TARGET DELINEATION IN VULVAL CANCER BY DR KANHU
 
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
Evolving Concepts in the Pathogenesis of Inflammatory Dermatologic Disorders ...
 
Ortho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limitedOrtho Products Franchise-solace biotech limited
Ortho Products Franchise-solace biotech limited
 
airway management recorded for S2.pptx
airway management  recorded  for S2.pptxairway management  recorded  for S2.pptx
airway management recorded for S2.pptx
 
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptxThyroid function tests for MBBS, LAB. MED & BDS.pptx
Thyroid function tests for MBBS, LAB. MED & BDS.pptx
 
(IDE)and(IVD),QMS,21 CFR part820 , 801)
(IDE)and(IVD),QMS,21 CFR part820  , 801)(IDE)and(IVD),QMS,21 CFR part820  , 801)
(IDE)and(IVD),QMS,21 CFR part820 , 801)
 
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdfEMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
EMBRYOLOGY AND FOETAL DEVELOPMENT-mayu.pdf
 
Explaining "pathology" in digital pathology
Explaining "pathology" in digital pathologyExplaining "pathology" in digital pathology
Explaining "pathology" in digital pathology
 
The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...The Art and the Science of UK General Practice A historical review and timeli...
The Art and the Science of UK General Practice A historical review and timeli...
 
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY  pptxHERPES SIMPLEX VIRUS 12032019 TUESDAY  pptx
HERPES SIMPLEX VIRUS 12032019 TUESDAY pptx
 
Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......Human Skeletal System_By Anupam Das......
Human Skeletal System_By Anupam Das......
 
Neutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractionsNeutraceuticals, Herb-drug & Herb-food inetractions
Neutraceuticals, Herb-drug & Herb-food inetractions
 

MCI brochure 2006

  • 1. PRESENTED BY: The Wien Center for Alzheimer’s Disease and Memory Disorders Mount Sinai Medical Center, Miami Beach, Florida and The Johnnie B. Byrd, Sr. Alzheimer’s Center & Research Institute Tampa, Florida and The Florida Alzheimer’s Disease Research Center Friday–Saturday, February 24-25, 2006 SYMPOSIUM LOCATION: Eden Roc Resort & Spa 4525 Collins Ave., Miami Beach, FL 33140 PROGRAM DIRECTOR Ranjan Duara, MD Medical Director Wien Center for Alzheimer’s Disease & Memory Disorders Mount Sinai Medical Center, Miami Beach, FL Departments of Medicine and Psychiatry Miller School of Medicine, University of Miami, Miami, FL SPONSORED BY: THE BEHRMAN CENTER FOR MEDICAL EDUCATION AT MOUNT SINAI MEDICAL CENTER An accredited interactive Symposium offering 15 hours of Category 1 credits for Physicians and 15 CEU accreditation hours for Psychologists offered through MAGEC. MILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUMMILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUM 44TH ANNUAL MCI Brochure 06 12/5/05 2:23 PM Page 2
  • 2. NEEDS ASSESSMENT Alzheimer’s Disease affects over 4 million persons in the United States and this number is projected to increase to over 13 million by 2050, due to increases in longevity and the aging of baby boomers. Continuing success in the development of new treatments and preventive measures for Alzheimer’s disease and other causes of dementia have prompted the need for a better recognition of the earliest stages of these conditions. The purpose of this symposium is to provide a forum where new information can be provided and in- depth discussions can take place about Mild Cognitive Impairment and all its subtypes. This will be accomplished via two keynote lectures and four mini- symposia. The symposium will feature a panel of national and international experts in the fields of neurology, psychiatry, geriatrics, neuropsychology, brain imaging, neuropathology and epidemiology. These experts will present updates on the early detection of incipient dementias and their causes, prevention and treatment. Each mini-symposium will be followed by an extended discussion period, allowing active audience participation to enhance the learning process. TARGET AUDIENCE This activity is designed for: – Neurologists – Psychiatrists – Geriatricians – Radiologists (neuroimaging specialists) – Epidemiologists – Neuropsychologists – Neuroscientists – Health Psychologists EDUCATIONAL OBJECTIVES The overall purpose of the symposium is to promote a better understanding and earlier diagnosis of mild cognitive impairment (MCI) and preclinical dementia. Upon completion of this symposium, the attendees should have a better understanding of the following: 1. Cognitive Reserve and MCI a. Cognitive reserve: Concept, measurement and significance for MCI b. Insights from longitudinal studies of aging c. Cognitive reserve perspectives from neuroimaging, neuropathology, and neuropsychology 2. Genetics of Cognitive Decline a. Inheritance of memory and cognitive performance in siblings of persons with Alzheimer’s Disease (AD) b. Genetics and gene expression of early AD and MCI c. Contribution of vascular genes in AD d. Genetics of the “normal” aging brain e. Prediction of MCI with plasma amyloid beta protein levels 3. Pathogenesis of Vascular/Metabolic Cognitive Impairment a. Cognitive impairment following stroke b. Epidemiology of vascular cognitive impairment c. Neuroimaging and neuropathology of vascular cognitive impairment 4. Systemic (Medical) and Psychiatric Considerations in MCI Diagnosis a. Contribution of physiological health to cognitive ability b. Effect of chemotherapy on cognitive function c. Effect of HIV infection and hepatitis C on cognition d. Depression and the diagnosis of MCI e. Anticholinergics, Benzodiazepines and MCI 5. Results of clinical trials in patients with MCI MCI Brochure 06 12/5/05 2:23 PM Page 3
  • 3. David A. Bennett, MD Professor of Neurological Sciences Rush University Medical Center Chicago, IL Monique Breteler, MD, PhD Professor of Neuroepidemiology Erasmus University Medical School Rotterdam, Netherlands Meryl Butters, PhD Associate Professor of Psychiatry University of Pittsburgh School of Medicine Pittsburgh, PA Mariana Cherner, PhD Assistant Professor of Psychiatry University of California San Diego School of Medicine San Diego, CA Helena Chui, MD McCarron Professor and Chair of Neurology University of Southern California Keck School of Medicine Los Angeles, CA Fiona Crawford, PhD Associate Director, Roskamp Institute Sarasota, FL Charles DeCarli, MD Professor of Neurology University of California Davis School of Medicine Sacramento, CA Steven DeKosky, MD Professor and Chairman of Neurology University of Pittsburgh School of Medicine Pittsburgh, PA Murali Doraiswamy, MD Director, Clinical Trials and Head, Biological Psychiatry Duke University Medical Center Durham, NC Lindsay Farrer, PhD Professor of Medicine, Neurology, Genetics & Genomics, Epidemiology, & Biostatistics Boston University Medical School Boston, MA Mary Ganguli, MD, MPH Professor of Psychiatry and Epidemiology University of Pittsburgh School of Medicine Pittsburgh, PA Cheryl Grady, PhD Professor of Psychiatry & Psychology Rotman Research Institute, University of Toronto Toronto, ON Canada Mary Haan, DrPH Professor of Epidemiology University of Michigan School of Public Health Ann Arbor, MI Walter Kukull, PhD, MS Professor of Epidemiology University of Washington School of Public Health and Community Medicine Seattle, WA Anand Kumar, MD Professor of Psychiatry University of California Los Angeles, CA Lenore Launer, PhD Chief, Neuroepidemiology Section National Institute on Aging Bethesda, MD Venkata Mattay, MD Chief, Unit on Clinical Neuroimaging National Institute of Metal Health Bethesda, MD Richard Mayeux, MD, MSc Professor of Neurology, Psychiatry and Epidemiology Columbia University College of Physicians and Surgeons New York, NY John Morris, MD Friedman Distinguished Professor of Neurology Washington University School of Medicine St. Louis, MO Daniel Mungas, PhD Adjunct Associate Professor of Neurology UC Davis School of Medicine Sacramento, CA Giulio Pasinetti, MD, PhD Professor, Psychiatry, Neuroscience & Geriatrics and Adult Development Mount Sinai School of Medicine New York, NY Ronald Petersen, MD, PhD Professor of Neurology and Alzheimer’s Disease Research Mayo Medical School, Rochester Rochester, MN Gustavo Roman, MD Professor of Neurology University of Texas Medical School San Antonio, TX Julie Schneider, MD Assistant Professor of Neurology and Neuropathology Rush University Medical Center Chicago, IL Brent Small, PhD Associate Professor of Aging Studies University of South Florida Tampa, FL Peter St. George-Hyslop, MD, DSc Professor of Neurology and Genetics University of Toronto Toronto, ON Canada John Starr, MD Consultant and Senior Lecturer, Geriatric Medicine University of Edinburgh Edinburgh, Scotland UK Yaakov Stern, PhD Professor of Clinical Neuropsychology Columbia University College of Physicians and Surgeons New York, NY Larry Tune, MD, MAS Professor and Chief of Geriatric Psychiatry Emory University Atlanta, GA Holly Tuokko, PhD Professor of Psychology University of Victoria Victoria, BC Canada Jeffrey Wefel, PhD Department of Neuro-Oncology University of Texas M.D. Anderson Cancer Center Houston, TX Lawrence Whalley, MD Crombie Ross Professor of Mental Health University of Aberdeen Aberdeen, Scotland UK Steven Younkin, MD, PhD Professor of Pharmacology and Pathology Mayo Clinic Jacksonville, FL DISTINGUISHED GUEST FACULTY Program Director Ranjan Duara, MD Medical Director, Wien Center for Alzheimer’s Disease & Memory Disorders Mount Sinai Medical Center, Miami Beach, FL Departments of Medicine and Psychiatry, Miller School of Medicine University of Miami, FL MCI Brochure 06 12/5/05 2:23 PM Page 4
  • 4. PM 2:00-4:15 Mini-Symposium: Genetics and Proteomics of Cognitive Decline Chair: Richard Mayeux, MD, MSc – Inheritance of Memory and Other Cognitive Functions in Siblings of AD Patients Richard Mayeux, MD, MSc – Genetic Factors in Alzheimer’s Disease and MCI Peter St. George-Hyslop, MD, DSc – Association of Vascular-Related Genes with AD Lindsay Farrer, PhD – Imaging Genetic Influences in Normal Cognitive Aging Venkata (Anand) Mattay, MD – Gene Expression Analysis and Proteomics in MCI and Early AD Giulio Pasinetti, MD, PhD – Plasma Amyloid Beta Protein Levels and the Prediction of MCI Steve Younkin, MD, PhD 4:15-5:15 Invited Discussant (Fiona Crawford, PhD) and General Discussion 5:15 Adjourn 7:00-9:00 Welcome Dinner Friday, February 24, 2006 AM 7:00-8:00 Breakfast Buffet 8:00-8:15 Welcome and Introduction Ranjan Duara MD 8:15-9:15 Vascular Risk Factors and Cognitive Reserve in the Evolution of Cognitive Decline and Dementia: Lessons from the Rotterdam Study Monique Breteler, MD,PhD – Keynote Speaker 9:15-11:30 Mini-Symposium: Cognitive Reserve and MCI Chair: Ronald Petersen, PhD, MD – Cognitive Reserve: Concept, Measurement and Significance for MCI Yaakov Stern, PhD – Cognitive Reserve: Insights from the Scottish Mental Survey (1947 & 1998) Lawrence Whalley, MD – Cognitive Reserve and the Neuropsychological Diagnosis of MCI Holly Tuokko, PhD – Cognitive Reserve: Structural Neuroimaging Daniel Mungas, PhD – Cognitive Reserve: Functional Neuroimaging Cheryl Grady, PhD – Cognitive Reserve and the Expression of AD Neuropathology David Bennett, MD 11:30-12:30 Invited Discussant (Walter Kukull, PhD and Brent Small, PhD) and General Discussion 12:30-2:00 LUNCH BREAK MCI Brochure 06 12/5/05 2:23 PM Page 5
  • 5. AM 7:00-8:00 Breakfast Buffet 8:00-8:15 Announcements and Introductions Ranjan Duara, MD 8:15-9:15 A Review of Clinical Trials in MCI Murali Doraiswamy, MD - Keynote Speaker 9:15-11:30 Mini-Symposium: Pathogenesis of Vascular/Metabolic Cognitive Impairment Chair: Steven DeKosky, MD – Pathogenesis of Cognitive Impairment Following Stroke Gustavo Roman, MD – Epidemiology of Vascular Cognitive Impairment Lenore Launer, PhD – Diabetes Mellitus and MCI Mary Haan, DrPH – Neuroimaging and Neuropatholgy in Vascular Cognitive Impairment Helena Chui, MD – Co-existence of Vascular and Alzheimer Pathology in Cognitively Impaired Individuals Julie Schneider, MD – Significance of White Matter Hyperintensities in MCI Charles DeCarli, MD 11:30-12:30 Invited Discussant (Richard Mayeux, MD, MSc) and General Discussion 12:30-2:00 LUNCH BREAK PM 2:00-4:00 Mini-Symposium: Systemic (Medical) and Psychiatric Considerations in MCI Chair: John Morris, MD – Physiological Health and Cognitive Ability in Aging John Starr, FRCP – Cancer, Chemotherapy and MCI Jeffrey Wefel, PhD – HIV infection, Hepatitis C and MCI Mariana Cherner, PhD – Depression, Vascular Disease & MCI Anand Kumar, MD – Anticholinergics, Benzodiazepines and MCI Larry Tune, MD 4:00-5:00 Invited Discussant (Mary Ganguli, MD, MPH and Meryl Butters, PhD) and General Discussion 5:00 Adjourn Saturday, February 25, 2006 MCI Brochure 06 12/5/05 2:23 PM Page 6
  • 6. METHOD OF REGISTRATION To register by mail or fax: please complete the registration form and send it with the payment to the above mailing address or fax number. To register by email: provide the information requested on the registration form in an e-mail message and send to: mcisymposium@msmc.com Registration confirmations will be issued. Payment: Registration fees can be paid by credit card or check, no cash is accepted. Please make all checks payable to MCI SYMPOSIUM, MSMC. Registration Fee Inclusions: Registration fees include admittance to all the scientific conferences, conference materials, validated parking, breakfast, lunch, refreshment breaks and welcome dinner as specified in the program. Registration Hours: The conference registration desk will be staffed: Friday, February 24 – Meeting Room: Cotillion Room 7:00 am - 5:00 pm Lunch: Topiary Garden 12:30 pm - 2:00 pm Welcome Dinner 7:00 pm - 9:00 pm Saturday, February 25 – Meeting Room: Cotillion Room 7:00 am - 5:00 pm Lunch: Harry’s 12:30 pm - 2:00 pm Refund Policy: Full refund will be given if written notice is received not later than January 27, 2006. All refunds will be processed after the meeting. REGISTRATION INFORMATION SYMPOSIUM LOCATION EDEN ROC RESORT & SPA: 4525 Collins Ave, Miami Beach, FL 33140 Phone: 1-800-327-8337 • Fax: 1-305-674-5555 Located on prime oceanfront property overlooking world-renowned Miami Beach and the spectacular Intracoastal Waterway, the 349-room Eden Roc Renaissance has been magnificently restored. From the beautifully carved Italian marble and mahogany reception desk to the highly polished original terrazzo floors, to the stunning grand circular lobby, the Eden Roc Renaissance welcomes guests with a gracious new contemporary spirit. Resort amenities include the Spa of Eden, one of the top fitness spas in the country, and two oceanfront pools. Directly behind the hotel is a raised 3- mile board walk, which invites leisure strolling or jogging next to the ocean. The world-famous South Beach Art Deco District and Lincoln Road Pedestrian Mall are just minutes away. HOTEL RESERVATIONS For the convenience of the 4th Annual MCI Symposium attendees, a limited number of rooms have been reserved at the special daily rate of $269.00 (single or double occupancy, plus resort fees, state and local taxes). To receive this special rate, reservations must be made directly with the Eden Roc Resort and Spa and you must mention that you are a registrant of the 4th Annual MCI Symposium. Rooms will be held at the special rate until Tuesday, January 27, 2006. Rooms at the discounted rate will be allocated on a first-come, first-served basis. Reservations received after the cut-off date are subject to availability and prevailing rates. FOR ROOM RESERVATIONS CALL: 1-800-327-8337 OR ACCESS THE HOTEL WEB SITE VIA www.byrdinstitute.org/MCISymposium MCI Brochure 06 12/5/05 2:23 PM Page 7
  • 7. 44TH ANNUAL MILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUMMILD COGNITIVE IMPAIRMENT (MCI) SYMPOSIUM REGISTRATION FORM THREE EASY WAYS TO REGISTER: ON LINE FAX US MAIL US www.byrdinstitute.org/MCISymposium Attn: Warren Barker Warren Barker Fax to (305) 674-2996 Wien Center 4300 Alton Road Miami Beach, FL 33140 REGISTRANT INFORMATION Please print: _________________________________________________________________________________________ LAST NAME FIRST NAME MI DEGREE: MD DO Ph.D OTHER ____________________________________________ _________________________________________________________________________________________ ADDRESS _________________________________________________________________________________________ CITY STATE ZIP CODE COUNTRY _________________________________________________________________________________________ E-MAIL FAX TELEPHONE REGISTRATION FEES: Physicians: Discounted: $290.00 (if dated/postmarked by January 27) $390.00 (if dated/postmarked after January 27) $450.00 (on site registration) Non-Physicians: Discounted: $225.00 (if dated/postmarked by January 27) $275.00 (if dated/postmarked after January 27) $325.00 (on site registration) $100.00 (students) PAYMENT METHOD: American Express Master Card Visa Check in the amount of________________ Card No. ________________________________________________ Expiration Date _____/_____ Cardholder’s Name _________________________________________________________________ Signature __________________________________________________________________________ Payment must accompany registration form MCI Brochure 06 12/5/05 2:23 PM Page 8
  • 8. ACCREDITATION Mount Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. Mount Sinai designates this continuing medical educational activity for a maximum of 15 Category 1 credits toward the American Medical Association Physician’s Recognition Award (AMA). Each physician should claim only those hours of credit that he/she actually spent in the educational activity. CEU ACCREDITATION A total of 15 Continuing Education credits for Psychologists will be offered through MAGEC (Miami Area Geriatric Education Center) DISCLOSURE STATEMENT Mount Sinai Medical Center in accordance with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME) will disclose the existence of any significant financial interest or other relationship between a faculty member or a sponsor has (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in the educational presentation and (2) with any commercial supporters of the activity. Faculty is also required to disclose to the audience, during their presentation, any investigational/ unlabeled use that is discussed. Information concerning Faculty relationship with industry will be disclosed and available on the Symposium Syllabus and on meeting site. CORPORATE SUPPORT This symposium is made possible by unrestricted educational grants from pharmaceuticals companies; our appreciation is expressed for their support of this program. Sponsors will be listed in our Symposium Syllabus. ACKNOWLEDGMENT This symposium is being supported by the Florida Alzheimer’s Disease Research Center. SYMPOSIUM INFORMATION Please contact: Warren Barker MCI Symposium Coordinator Wien Center for Alzheimer’s Disease & Memory Disorders Mount Sinai Medical Center Phone: 305-674-2592 – Fax: 305-674-2996 E-mail: mcisymposium@msmc.com Wien Center 4300 Alton Road Miami Beach, FL 33140 44TH ANNUAL MCIS Y M P O S I U M FEBRUARY 24th & 25th 2006 For information please contact: Warren Barker Phone: 305-674-2592 mcisymposium@msmc.com www.byrdinstitute.org/MCISymposium MCIS Y M P O S I U M For information please contact: Warren Barker Phone: 305-674-2592 mcisymposium@msmc.com www.byrdinstitute.org/MCISymposium MCI Brochure 06 12/5/05 2:23 PM Page 1